www.worldpharmaceuticals.net
News, views and contacts from the global World Pharmaceuticals industry
Weekly Round Up
25 January 2022
Latest Companies

CSafe Global

World leader of peptide, peptide reagents, antibodies and related products

SKYPORT TO HANDLE FINNAIR CARGO AT PRAGUE AIRPORT

Managing vendors means managing relationships

The Single Source for Clinical Trial Ancillary Supply Chain™

Features

The smart money
Smart packaging offers huge value to the whole of the supply chain. There are a number of recent innovations that can help optimise monitoring. Louise Thomas speaks to Ruud van der Geer, associate director of supply chain management EMEA at MSD, about the opportunities and future directions within the field.

Counterfeit and proper
The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through its work with the PharmaLedger consortium, is adding a blockchain-powered layer of authenticity to pharma packaging by talking with Daniel Fritz, a supply chain technology architect at the company.

Waste not, want not
The health sector is responsible for an estimated 4.4% of global greenhouse gas emissions – the vast majority of which originate in the supply chain. One of the easiest ways to start addressing that is to focus on recycling and reusing materials, as the first comprehensive life-cycle assessment of reprocessed versus disposed ‘single-use’ devices makes clear. How can original equipment manufacturers (OEMs) weigh up the pros and cons of recycling and reprocessing, and use this insight to make their own work more sustainable? Monica Karpinski finds out.

Mind the skills gap
There’s a skills shortage in the world of cell and gene therapy. This isn’t news; the problem has endured for years without a solution – but could that be because there isn’t one? Peter Littlejohns asks academic turned consultant William Janssen, who has spent a lifetime researching and applying cells in cancer clinics; Sarah Stoll, director of biomanufacturing consultancy Project Farma; and James Kusena, head of bioprocessing at cell manufacturing technology start-up MicrofluidX, whether the talent shortfall can be overcome.

Counterfeit and proper
The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through its work with the PharmaLedger consortium, is adding a blockchain-powered layer of authenticity to pharma packaging by talking with Daniel Fritz, a supply chain technology architect at the company.


You are receiving this email because you are either a valued subscriber to World Pharmaceutical Frontiers or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

Global Trade Media, a trading division of SPG Media Ltd | Registered office: John Carpenter House, John Carpenter Street, London, EC4Y 0AN | Registered in England No. 01155599.